Back to search

Article

Determinants of primaquine and carboxyprimaquine exposures in children and adults with<i>Plasmodium vivax</i>malaria

2021-07-06

Abstract excerpt

<h4>Background</h4> Primaquine is the only widely available drug for radical cure of Plasmodium vivax malaria. There is uncertainty whether the pharmacokinetic properties of primaquine are altered significantly in childhood or not. <h4>Methods</h4> Glucose-6-phosphate dehydrogenase normal patients with uncomplicated P. vivax malaria were randomized to receive either chloroquine (25mg base/kg) or dihydroartemisinin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f7e90573-1319-5e3a-afdd-40489709bd1c
DOI
10.1101/2021.07.05.21259877
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Determinants of primaquine and carboxyprimaquine exposures in children and adults with<i>Plasmodium vivax</i>malariaDOI 10.1101/2021.07.05.21259877
High daily dose Short COurse PrimaquinE after G6PD testing for the radical cure of<i>Plasmodium vivax</i>malaria in Indonesia and Papua New Guinea: The SCOPE implementation study protocolSemantic proximity
Efficacy and safety of dihydroartemisinin-piperaquine for the treatment of uncomplicated <i>Plasmodium falciparum</i> and <i>Plasmodium vivax</i> malaria in Northern Papua and Jambi, IndonesiaSemantic proximity
Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.Semantic proximity
The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data.Semantic proximity
Strong gene dose dependent protective effect of Mediterranean type glucose-6-phosphate dehydrogenase deficiency against <i>Plasmodium vivax</i> malariaSemantic proximity
Influence of CYP2C19, CYP2D6 and CYP3A4 genetic variants on the biological effect of malaria treatment with primaquine in G6PD- deficient and G6PD-normal patientsSemantic proximity
Primaquine-derived 5,6-orthoquinone concentrations in urine associated with CYP2D6 genotype-predicted phenotype and blood methemoglobin levels.Semantic proximity
A <i>Plasmodium vivax</i> controlled human infection and transmission model to evaluate interventions across the life cycleSemantic proximity
Pharmacometric evaluation of amodiaquine-sulfadoxine-pyrimethamine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern UgandaSemantic proximity
Pharmacometric assessment of primaquine induced haemolysis in glucose-6-phosphate dehydrogenase deficiencySemantic proximity
Effects of Host Genetic Polymorphisms on the Efficacy of the Radical Cure Malaria Drug PrimaquineSemantic proximity
Single Low Dose Primaquine (0.25mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient SubjectsSemantic proximity
Select a neighboring publication to make it the new centre.